#153655

Anti-Myostatin [Myo2/1A]

Cat. #153655

Anti-Myostatin [Myo2/1A]

Cat. #: 153655

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: Myostatin

Class: Monoclonal

Application: WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: BioServ UK Ltd

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: Anti-Myostatin [Myo2/1A]
  • Alternate name: Growth/differentiation factor 8, GDF-8, myostatin, GDF8, MSTN
  • Clone: Myo2/1A
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Purpose: Marker
  • Conjugation: Unconjugated
  • Molecular weight: 52 kDa
  • Reactivity: Human
  • Host: Mouse
  • Application: WB
  • Description: Myostatin is a well-characterized negative regulator of skeletal muscle and can inhibit myogenesis and stimulate adipogenesis. Clone Myo 2/1A has been shown to have the reverse effect, up-regulate myogenesis and down-regulate adipogenesis.
  • Immunogen: Recognizes the 113 amino acid carboxy-terminal fragment of Myostatin protein
  • Myeloma used: Sp2/0-Ag14
  • Recommended controls: Muscle fibre

Target Details

  • Target: Myostatin
  • Molecular weight: 52 kDa
  • Tissue cell line specificity: Mouse
  • Target background: Myostatin is a well-characterized negative regulator of skeletal muscle and can inhibit myogenesis and stimulate adipogenesis. Clone Myo 2/1A has been shown to have the reverse effect, up-regulate myogenesis and down-regulate adipogenesis.

Applications

  • Application: WB

Handling

  • Format: Liquid
  • Unit size: 100 ug
  • Shipping conditions: Shipping at 4° C

References

  • Artaza et al. 2005. Endocrinology. 146(8):3547-57. PMID: 15878958.
  • Myostatin inhibits myogenesis and promotes adipogenesis in C3H 10T(1/2) mesenchymal multipotent cells.